Biologic Drugs With Established Pharmaceutical Class: Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Immunocore Limited | KIMMTRAK | tebentafusp-tebn | Injection | 761228 | 2022-01-25 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |